News

SWITZERLAND INNOVATION PARK BASEL AREA WELCOMES NEW RESIDENTS IN APRIL 2018

The Park Basel Area community is growing – we are delighted to welcome four new startups in April.

With Polyneuron Pharmaceuticals, a spin-off from University of Basel, and the Polish biotech startup Captor Therapeutics, Park Basel Area gains new experts in the field of innovative health-oriented life sciences.

The French biotech startup Algae Natural Switzerland, which aims to contribute to a healthier nutrition with its microalgae, and a recently founded medtech company in stealth mode further expand the startup portfolio.

Algae Natural Switzerland
Algae Natural Switzerland AG provides protein and/or omega-3 rich high-quality microalgae for food and feed applications. The company’s production process for organic microalgae is developed based on a sustainable and circular approach for a successful eco-conception.

Captor Therapeutics
Captor Therapeutics is a Polish biotech company developing drug candidates for the treatment of oncology and chronic inflammation.

Polyneuron Pharmaceuticals
Polyneuron Pharmaceuticals is a spin-off from the University of Basel focusing on the development of a promising new drug class to treat autoimmune disorders.

Medtech company in stealth mode.

«You may also like»

Basel is a hotspot for innovation

Basel is an international hub for innovative companies. This has been found in a ranking of…> Read more

Fully equipped lab spaces at the Switzerland Innovation Park Basel Area

Launching a biotech is a daunting endeavor. Resources – both human and capital - are scarce…> Read more

150 Scientists Working on Life Sciences Innovation

The community at Switzerland Innovation Park Basel Area keeps growing. We are delighted to present our…> Read more